2020 annual financial data
Viking Therapeutics 2020 Operating margin
Direct answer
Operating margin was -397,558.48%.
Operating income was -42,662,000 USD and net income was -39,495,000 USD.
Operating cash flow was -21,777,000 USD.
Get free Viking Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,731 USD
- Operating income
- -42,662,000 USD
- Net income
- -39,495,000 USD
- Operating cash flow
- -21,777,000 USD